Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06454344Not ApplicableRecruiting

The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies

Role: lead

NCT07073352Not ApplicableRecruiting

ACEs, SIRT1, and Premature Vascular Aging in Humans

Role: lead

NCT06890962Not ApplicableCompleted

Citicoline Dose on Energy Drink Efficacy

Role: lead

NCT05928195Not ApplicableCompleted

Acute Effects of Organic Guayusa Extract

Role: lead

NCT05559372Not ApplicableCompleted

Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes

Role: lead

NCT05820399Not ApplicableCompleted

Guayusa Extract on Exercise Training

Role: lead

All 6 trials loaded